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Background: Although vocational rehabilitation is a widely advocated intervention for workers on sick leave due to
subacute or chronic nonspecific musculoskeletal pain, the optimal dosage of effective and cost-effective vocational
rehabilitation remains unknown. The objective of this paper is to describe the design of a non-inferiority trial evaluating
the effectiveness and cost-effectiveness of 40-h multidisciplinary vocational rehabilitation compared with 100-h
multidisciplinary vocational rehabilitation on work participation for workers on sick leave due to subacute or chronic
musculoskeletal pain.
Methods/Design: A non-inferiority study design will be applied. The study population consists of workers who are on
part-time or full-time sick leave due to subacute or chronic nonspecific musculoskeletal pain. Two multidisciplinary
vocational rehabilitation programs following the bio-psychosocial approach will be evaluated in this study: 40-h
vocational rehabilitation and 100-h vocational rehabilitation, both delivered over a maximum of 15 weeks. The 100-h
vocational rehabilitation comprises five modules: work participation coordination, graded activity, cognitive behavioral
therapy, group education, and relaxation. The 40-h vocational rehabilitation comprises work participation coordination
and a well-reasoned choice from the other four modules. Four rehabilitation centers will participate in this study,
each delivering both interventions. Patients will be randomized into one of the interventions, stratified for the duration
of sick leave (<6 weeks or ≥6 weeks) and type of sick leave (part-time or full-time). The primary outcome is work
participation, measured by self-reported sick leave days, and will be assessed at baseline, mid-term, discharge, and
at 2, 4, 6, 8, 10, and 12 months follow-up. Secondary outcomes are work ability, disability, quality of life, and physical
functioning and will be assessed at baseline, discharge, and at 6 and 12 months follow-up. Cost outcomes are
absenteeism, presenteeism, healthcare usage, and travelling costs. Cost-effectiveness will be evaluated from the societal
and employer perspectives.
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Discussion: The results obtained from this study will be useful for vocational rehabilitation practice and will provide
stakeholders with relevant insights into two versions of vocational rehabilitation.
Trial registration: Dutch Trial Register identifier: NTR4362 (registered 17 March 2014).
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Chronic musculoskeletal pain is a major health problem
associated with decreased functioning and quality of
life, sick leave, and increased direct and indirect med-
ical costs [1–4]. The majority of the costs (48 to 88 %)
are attributed to indirect costs due to sick leave from
work or productivity loss while at work [5, 6]. Chronic
musculoskeletal pain arises when acute musculoskeletal
pain does not disappear within 6 weeks, which occurs
in 10–20 % of the cases [7]. After a duration of 6 weeks,
it is considered subacute musculoskeletal pain (SMP),
and if the pain is still present after 12 weeks, it is con-
sidered chronic musculoskeletal pain (CMP) [8]. If
there is no clear medical explanation, the chronic mus-
culoskeletal pain is called “nonspecific.”
Vocational rehabilitation is a widely advocated inter-
vention for sick-listed workers with subacute or chronic
nonspecific musculoskeletal pain [9–12]. Vocational re-
habilitation is “a multiprofessional evidence-based ap-
proach that is provided in different settings, services,
and activities to working-age individuals with health-
related impairments, limitations, or restrictions with
work functioning and whose primary aim is to optimize
work participation” [13]. In addition, work participation
is conceptualized as the involvement in work roles or
the lived experience of work. Work participation restric-
tion refers to problems an individual may experience at
work. Examples include number of hours lost from work
(that is, absenteeism), underperforming job expectations,
reduced desired employment (for example, part-time
employment, short-term disability, long-term disability,
premature retirement, or fewer working hours than de-
sired), and reduced career growth [14]. However, in this
paper, work participation (restriction) is expressed as the
number of sick leave days due to subacute or chronic
musculoskeletal pain. Research shows that vocational re-
habilitation improves return to work [9–12, 15–22], and
thus facilitates work participation. However, the dose-
effect relation of vocational rehabilitation on work par-
ticipation is unclear. Several reviews on the effectiveness
of vocational rehabilitation on work participation for
sick-listed workers with SMP and CMP show a wide
range in treatment hours [9, 11, 20, 23]. In addition, a
systematic review revealed a range of 6.4 to 196.8 hours
in pain rehabilitation programs [23]. So far, only onerandomized controlled trial has compared the dose-
effect relation of vocational rehabilitation (VR) [16].
Sick-listed workers with CMP were classified at baseline
as good, medium, or poor based on their prognosis for
return to work (that is, return to work defined by the
authors as absence of sick pay or related benefits in a
given month), and were thereafter randomized to exten-
sive VR (approximately 120 treatment hours), light VR
(approximately 20 to 30 treatment hours), or care as
usual (referred back to general practitioner). After 14
months follow-up, the participants classified with poor
prognosis benefited most from the extensive VR, result-
ing in higher return to work rates, whereas patients clas-
sified with medium prognosis benefited from both the
light and extensive programs on improving return to
work rates. In another paper, but using the same study
construct and population as in the Haldorsen trial [16],
results were obtained without the prognosis on return to
work (that is, good, medium, or poor) and on a follow-
up period of two years. After 2 years follow-up, the light
VR resulted in the highest return to work rates com-
pared with usual care, but significance was only found in
men. Additionally, the authors found no significant dif-
ference on return to work rates between light and exten-
sive VR or between extensive VR and usual care [24].
As resources in healthcare are scarce, it is necessary to
provide stakeholders information on the cost-effectiveness
of intervention programs. Economic evaluations (cost-
effectiveness studies) provide information on the relative
efficiency of two or more alternative interventions. The
main aspects of any economic evaluation are to identify,
measure, value, and compare the costs and consequences
of alternatives [25]. A randomized controlled trial found
that a participatory approach (approximately 40 treatment
hours consisting of a workplace intervention and graded
activity) for sick-listed patients with chronic back pain was
cost-effective on work participation (that is, return to
work) compared with usual care [18]. Similar interven-
tions conducted in subacute low back pain patients also
show promising results on cost-effectiveness [21, 24, 26,
27]. However, there are no studies known that compare
the cost-effectiveness of two (or more) vocational rehabili-
tation programs. To provide relevant stakeholders (that is,
patients, referrers, employers, vocational rehabilitation
centers, healthcare insurers, and policy makers) with
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rehabilitation, a comparison of two versions of vocational
rehabilitation is needed.
Objectives
The objective of this paper is to describe the design of
a multicenter, randomized, non-inferiority study to
evaluate the effectiveness and cost-effectiveness of 40-h
vocational rehabilitation compared with 100-h voca-
tional rehabilitation on work participation for patients
with subacute or chronic musculoskeletal pain and with
sick leave from work. We hypothesize that 40-h VR will
be noninferior on work participation and cost-effective
in comparison with 100-h VR.
The research questions are:
I) For workers on sick leave due to subacute or chronic
musculoskeletal pain, is 40-h vocational rehabilitation
noninferior on work participation compared with
100-h vocational rehabilitation?
II) For workers on sick leave due to subacute or chronic
musculoskeletal pain, is 40-h vocational rehabilitation




In the description of our study design, we follow the
Consolidated Standards of Reporting Trials (CONSORTFig. 1 Flow chart of the design of the studystatement) with the extension of reporting on non-
inferiority trials [28].
Organization of the study
Approval for the study has been obtained by the Medical
Ethics Committee of the Academic Medical Center,
Amsterdam, the Netherlands (approval number: 2013_366).
The trial is registered in the Dutch Trial Register (http://
www.trialregister.nl/trialreg/index.asp) with identification
number NTR4362. All participants will sign written in-
formed consent forms and will be insured according to
Dutch Law in case of any damage caused by participation
in the study. Figure 1 shows a flow chart of the design of
the study.
Study design
A multicenter, randomized, 12-month follow-up, non-
inferiority study design will be performed to evaluate the
effectiveness and cost-effectiveness on work participa-
tion of 40-h versus 100-h vocational rehabilitation for
patients with subacute or chronic musculoskeletal pain
and on sick leave from work.
Study population
The inclusion criteria for this study are as follows: 1) in-
dividuals of working age (18 to 65 years); 2) suffering
from subacute (6 to 12 weeks) or chronic (>12 weeks)
nonspecific musculoskeletal pain such as back, neck,
shoulder, widespread pain, Whiplash Associated Disorder
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(employed or self-employed) for at least 12 hours per
week; 4) the expectation that the employment or self-
employment will not be terminated in the year following
the vocational rehabilitation program; 5) having short-
term (<6 weeks) or long-term (≥6 weeks) part-time or
full-time sick leave; 6) being able to understand Dutch
and able to complete questionnaires in Dutch; 7) having
the motivation to participate in vocational rehabilitation
aimed at optimizing work participation; 8) reimbursement
of program costs by the employer (that is, the work par-
ticipation coordination module, see Appendix 1); 9) hav-
ing an email address; and 10) having granted informed
consent. The exclusion criteria for this study is having co-
morbidities that are the primary reason for sick leave, such
as acute or specific medical problems, clinical depression
or burnout, severe asthmatic symptoms, diagnosed
chronic fatigue, and neuropathy.
Setting
Patients will be recruited between November 2014 and
August 2016. The study will be performed in four voca-
tional rehabilitation centers in the Netherlands that are
part of a nationwide network of twelve VR centers. The
four participating centers in this study are geographically
spread across the Netherlands and have been selected
according to the number of patients expected to be re-
ferred in 2014 to 2016.
Recruitment of participants
Recruitment of participants occurs in five steps; the first
three steps are regular steps and the last two steps have
been added especially for this study. Step 1. Patients will
be referred to one of the four participating centers by ei-
ther an occupational physician, medical specialist, general
practitioner, or employer. Step 2. A rehabilitation phys-
ician (RP) will assess the patient’s medical history, bio-
psychosocial restrictions, and work-related limitations.
Step 3. A multidisciplinary screening comprising a mental,
physical and occupational assessment will take place,
which will be performed by a psychologist, physiotherap-
ist, and occupational specialist. Step 4. After completing
the multidisciplinary screening, the patient will be pro-
vided with verbal and written information about the study.
When all study criteria have been met, which will be de-
cided by the RP, the patient will be asked to sign the in-
formed consent form. Step 5. When the patient has
granted written informed consent, the patient will be ran-
domized into 40-h or 100-h vocational rehabilitation.
Interventions
40-hour vocational rehabilitation
The 40-h vocational rehabilitation is a multidisciplinary
bio-psychosocial [29] group-based program and consistsof work participation coordination (10 h), and a choice
of 30 h of a set of modules offered in the 100-h
vocational rehabilitation program, such as graded activ-
ity, cognitive behavioral therapy, group education, and
relaxation. These modules are described in detail in
Appendix 1. Since the choice of 30 h of modules will be
prioritized by the multidisciplinary screening team after
the multidisciplinary screening at baseline, the content
may differ among patients. The 40-h VR lasts a max-
imum of 40 h in 15 weeks. Each rehabilitation center
will prioritize the number of sessions per participant per
week, but the following framework will be a guideline
for the rehabilitation centers: weeks 1-5 two sessions/
week, weeks 6-10 one session/week, weeks 11-15 2-3
sessions in five weeks. The 40-h VR program will be ex-
tended in case of the following: a patient’s percentage of
working hours per week pertaining to contract hours at
discharge compared with working hours per week per-
taining to contract hours at baseline is extended by 25
to 50 %, and the multidisciplinary team expresses strong
arguments that the patient is likely to benefit from the
extension. However, this protocol deviation should occur
in no more than 5 % of the cases. This percentage is ar-
bitrarily chosen by the authors of this paper; if more
than 5 % of the participants deviate from the study
protocol, the robustness on non-inferiority (that is, re-
search question 1) will decline [30].
100-hour vocational rehabilitation
The 100-h vocational rehabilitation is a multidisciplinary
bio-psychosocial group-based program and encom-
passes a set of modules: work participation coordin-
ation, graded activity, cognitive behavioral therapy,
group education, and relaxation. These modules are
described in detail in Appendix 1. The 100-h VR con-
sists of approximately 100 h and is an existing VR
program in the Netherlands conducted by 12 rehabili-
tation centers, four of which will participate in this
study. The 100-h VR is delivered over a period of 15
weeks with two sessions (approximately 3.5 h/session)
per week. The 100-h VR appears similar to other VR
trials [17, 31] but has a longer duration (in weeks)
and consists of more graded activity hours compared
to similar studies [18, 21, 32].
Data collection
Self-reported data will be collected using web-based
questionnaires. Data will be collected at baseline (that is,
before and during the multidisciplinary screening, T0), 7
weeks after the start of the intervention (midterm, T1),
14 weeks after the start of the intervention (discharge,
T2), and at 2, 4, 6, 8, 10 and 12 months follow-up after
discharge (T3-T8). Figure 2 shows the timing of the data
collection. In addition, pilot data show an expected delay
Fig. 2 Timing of data collection
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start of the intervention. At each data point, participants
will receive an email with login data and the request to
complete questionnaires on a website. If participants do
not complete the questionnaire within a week, they will
receive a reminder email. If the questionnaire is not
completed after this reminder, patients will be tele-
phoned by a researcher (TB), who will ask patients to
complete the questionnaire. Table 1 presents the out-
come measures of the data collection.
Outcome measures
The selection process of the questionnaires used in this
study and information about their validity and reliability
is described in a core set paper [33]. Primary, secondary,
and cost outcomes will be assessed to answer the re-
search questions.
Primary outcome
The primary outcome in this study is work participation
expressed as total sick leave days due to subacute or
chronic musculoskeletal pain. Total sick leave days will be
calculated from the start of the intervention until 12
months follow-up after discharge. Sick leave will be mea-
sured using the absenteeism items of the iMTA (institute
for Medical Technology Assessment) Productivity Cost
Questionnaire (iPCQ) [34]. The questionnaire has a recall
period of 4 weeks and measures sick leave on working
days and on a generic basis (that is, the reason for sick
leave is not asked). We have made slight adaptations to
measure sick leave specifically (that is, related to subacute
or chronic musculoskeletal pain, or other reasons such as
flu), and we have added an item to assess the working
hours at this moment: “Are you working for the full num-
ber of hours you were contracted for?” This question has
three possible answers: “yes,” “no, I am partly at work,”
and “no, I am on 100 % sick leave.” After the answer “no, Iam partly at work” the participant is asked to fill in the
number of hours he/she is working per week at that mo-
ment. The iPCQ is the result of combining two existing
Dutch questionnaires (PRODISQ and SF-HLQ), and is
recommended by the Dutch guideline for health economic
evaluations [35]. The iPCQ has been translated by a pro-
fessional language institution into a patient-friendly ver-
sion using more simple language, thereby increasing the
feasibility and validity of the questionnaire [34]. A popula-
tion with mental health problems showed a satisfactory
reliability regarding the iPCQ absenteeism items (icc 0.83)
[36]. Until now, reliability of the iPCQ has not been tested
in our study population. This needs to be done in the near
future.
Secondary outcomes
Secondary outcomes include the following:
1. Work ability will be measured using a single item
of the Work Ability Index (WAI) [37]. The current
work ability compared to lifetime best work ability
can be scored on a 0 to 10 response scale, where 0
represents “completely unable to work” and 10
represents “work ability at its best”.
2. Disability will be measured using the Pain Disability
Index (PDI). The PDI is a 7-item questionnaire for
investigating the magnitude of the self-reported
pain-related disability, independent of region of pain
or pain-related diagnosis. The PDI measures family/
home responsibilities, recreation, social activity, oc-
cupation, sexual behavior, self-care, and life support
activity. The questionnaire is constructed according
to a 0 to 10 numeric rating scale in which 0 means
no disability and 10 maximum disability. Total
scores can range from 0 to 70, with higher scores
reflecting higher interference of pain with daily
activities [38, 39].
Table 1 Outcome measures for each of the measurement moments
Outcomes Time measured Follow-up
Baseline Midterm Discharge 2 months 4 months 6 months 8 months 10 months 12 months
T0 T1 T2 T3 T4 T5 T6 T7 T8
Descriptive variables
Demographic variables x
General perceived health x
Work-related psychosocial factors x
Self-efficacy of work participation x
Pain intensity x x
Fatigue x
Work tolerance functions x
Outcome measures
Primary
Work participationa x x x x x x x x x
Secondary
Work ability x x x x
Disability x x x x
Physical functioning x x x x
Quality of life x x x x
Costsa
Presenteeism x x x x x x x x x
Health care usage x x x x x
aThe primary outcome work participation will also serve as a cost outcome (that is, absenteeism)
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physical functioning subscale of the RAND-36. The
questionnaire assesses self-reported physical func-
tioning independent of (pain) diagnosis [40]. The
physical functioning scale consists of 10 questions
with three possible answers: “yes, limited a lot,” “yes,
limited a little,” and “no, not limited at all.” The total
score can range from 0 to 100, with higher scores
indicating better physical functioning. The validity
and reliability of the Dutch version are good [41].
4. Quality of life will be measured using the validated
Dutch version of the EuroQol-5D (EQ-5D) [42, 43].
The EQ-5D measures five dimensions: mobility, self-
care, activities of daily life, pain and anxiety/depression
on a categorical scale (1 to 3). The EQ-5D is a widely
employed instrument used to assess health-related
quality of life (QoL), and is recommended by the
Dutch guideline for health economic evaluations [35].
To allow comparison between several conditions and
interventions, Quality Adjusted Life Years (QALYs)
will be calculated in three steps. First, the EQ-5D
scores (measured at baseline, discharge, 6-month
follow-up, and 12-month follow-up) will be converted
to utility scores using the Dutch EQ-5D tariff [43].
Second, QALYs will be calculated from three timeperiods (1 = baseline to discharge, 2 = discharge to
the 6-month follow-up, 3 = 6-month follow-up to the
12-month follow-up). Third, one summated QALY
will be calculated from the calculated QALYs in step
two.
Cost outcomes
The following outcomes will be assessed to evaluate the
cost-effectiveness of the 40-h VR compared with the
100-h VR:
1. Absenteeism data will be derived from the work
participation (that is, primary outcome) data in this
study.
2. Presenteeism will be assessed using the presenteeism
items of the iPCQ [34]. The questionnaire measures
the total days of mental or physical complaints at
work, with a recall period of 4 weeks. The amount
of work performed accompanied by mental or
physical complaints is measured on a 0 to 10
response scale, where 0 represents “I couldn’t do
anything,” to 5 “I could do about half of normal,” to
10 “I could do the same as normal.” A population
with mental health problems showed good feasibility
and validity [34], and moderate reliability for the
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complaints (icc 0.56), and a satisfactory reliability for
the efficiency rate (0 to 10) item (icc 0.73) [36].
3. Healthcare usage will be assessed using the
Trimbos iMTA questionnaire for measuring Costs
of Psychiatric Illnesses (TiC-P), module 1 [36, 44].
A recall period of 4 weeks is used in this
questionnaire. Visits and consultations of the
following healthcare providers were measured:
general practitioner, physiotherapist, manual
therapist, exercise therapist, occupational therapist,
psychologist, insurance physician, medical
specialists in hospitals, hospitalization (number of
days), occupational physician, social worker, and
dietician. Additional items were alternative care,
home care, medication use, and job-related care like
job coaches, ergonomic changes at the work site
and reintegration specialists. Slight adaptations in
the context and scope of health care practitioners
were made to better match TiC-P to the target
population (that is, from psychiatry to pain and
work). Another modification was that visits and
consultations were measured in both generic and
sickness-specific terms. Research shows that health
care usage assessment by means of self-reported
questionnaires is reliable [45]. A population with
mental health problems showed good feasibility,
promising construct validity, good agreement on
medical resource use (yes/no), and sufficient test-
retest reliability on the number of contacts with the
health care providers [36]. Until now, reliability of
the TiC-P has not been tested in our study popula-
tion. This needs to be done in the near future.
Patient characteristics
Patient characteristics will be collected at baseline (that
is, before and during the multidisciplinary screening) to
evaluate if randomization resulted in two prognostically
comparable groups. The following characteristics will be
collected:
1. Demographic variables: age, gender, marital status,
nationality, body mass index (obtained from self-
reported weight and height), educational level, and
health condition [46, 47].
2. General perceived health will be assessed using a
single item of the RAND-36 questionnaire [41].
3. Work-related psychosocial factors will be assessed
using the Work Reintegration Questionnaire
(WRQ). The questionnaire consists of 78 items
distributed across eight scales: distress, illness
behavior/coping, job strain, job satisfaction, job
control, avoidance, perfectionism, and stressful
home situation. The questionnaire was developedand validated in Dutch (VAR: vragenlijst
arbeidsreintegratie) [48, 49].
4. Self-efficacy of work participation will be assessed on
a 0 to 10 response scale. Participants rate the
certainty that they will be working in 6 month’s
time, where 0 represents “not at all certain” to 10
“extremely certain.” A score of ≥5 is associated with
successful work participation after 6 months for
workers with subacute back pain [50].
5. Pain intensity and fatigue will each be measured
using two questions from an 11-point Numeric Rat-
ing Scale, ranging from 0 “no pain/fatigue” to 10
“worst possible pain/fatigue,” requiring patients to
rate their worst and average intensity of the last 7
days [51].
6. Work tolerance functions will be assessed at baseline
during the multidisciplinary screening using
standardized lifting capacity tests from the
Functional Capacity Evaluation (FCE) test battery:
lifting low and/or overhead lifting. The lifting tests
to be assessed depend on the individual’s work tasks.
Procedures are described in detail elsewhere [52].
Lifting tests were found to be predictive of work
participation in patients with musculoskeletal
disorders [53].Non-inferiority hypothesis
A reduction in sick leave days of more than 30 days per
year is deemed a clinically significant improvement on
work participation [15, 17–19, 24]. A difference in sick
leave days of 30 or fewer (from the start of the interven-
tion until 12-months follow-up) between 40-h and 100-h
VR is assigned as the margin of non-inferiority in this
study. Our hypotheses are as follows:
H0: μ1 - μ2 ≥30
H1: μ1 - μ2 <30
H0 is the null hypothesis, and H1 is the alternative hy-
pothesis, μ1 is the mean number of sick leave days in
the 40-h VR group, and μ2 is the mean number of sick
leave days in the 100-h VR group.
Non-inferiority is claimed if the upper bound of the
one-sided 95 % confidence interval of the treatment ef-
fect difference (μ1 - μ2) on work participation does not
exceed 30, which means that the risk of it being inferior
is within acceptable boundaries [30]. We expect a nor-
mal distribution of the primary outcome work participa-
tion. If the data on the primary outcome does not follow
a normal distribution, we will perform log transforma-
tions. The margin of non-inferiority will then be inter-
preted as a 28 % increase in the sick leave days’ difference
of μ1 - μ2. We calculated this percentage as follows:
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where 30 denotes the margin of non-inferiority and 107
the expected mean days of sick leave in the 100-h VR
arm [15, 17–19, 24] during the timing of the data collec-
tion, which equals approximately 15.5 months (interven-
tion period of 3.5 months + the follow-up period of 12
months, see Fig. 2).
Statistical methods
All statistical analyses will be performed at the patient
level, with descriptive statistics being used to compare
the baseline measurements of the two intervention
groups. If necessary, analyses will be adjusted for base-
line differences. All analysis will be performed according
to the intension-to-treat principle and the per protocol
principle [30, 54]. To claim non-inferiority, both
intention-to-treat and per protocol analysis must show
non-inferiority [54]. Missing data on costs and effects
will be assessed using multiple imputation techniques
[25]. The imputation technique will depend on the re-
sults (that is, missing completely at random, missing at
random, or missing not at random).
Effectiveness
The primary outcome work participation will be ana-
lyzed in three steps. Step 1. For every time point (that is,
T0 - T8, see Fig. 2), we will present the number of sick
leave days as an absolute number and as a percentage
related to contract hours/month, in which the absolute
number and percentages between a given time point and
the preceding time point will be calculated using linear
extrapolation, as recommended [36, 44, 55]. Step 2. We
will calculate and present the cumulative total days of
sick leave per month from the start of the intervention
until the 12-month follow-up using an area under the
curve for all measurement points, in which the number
of sick leave days between a given time point and the
preceding time point will be calculated using linear ex-
trapolation. Step 3. Linear mixed models with multilevel
analyses will be performed to assess non-inferiority be-
tween the two groups at the 12-month follow-up (that
is, intervention period and 12-month follow-up) by
means of 95 % confidence intervals (that is, the CI ap-
proach). To improve generalizability and comparability
of this study with other studies, we will repeat step 3 at
the following time intervals: I) discharge to 12-month
follow-up; II) start of intervention to 6-month follow-up;
III) discharge to 6-month follow-up. These additional
analyses will contain no conclusions about non-inferior-
ity and will be analyzed in the “classical” superiority
manner.
A t-test or Mann–Whitney U test (in the case of no
normal distribution) will be used to examine differencesat discharge, at 6-month follow-up, and at 12-month
follow-up (defined as the difference in outcome between
baseline and last follow-up) in all secondary outcomes
between the intervention groups. We will perform these
analyses on superiority, thus without margins of non-
inferiority, as this is only relevant for the analysis of the
primary outcome.
Cost-effectiveness
Various kinds of economic evaluations are recom-
mended for the same study to inform all relevant stake-
holders [25]. We will perform three types of cost
analysis: cost-effectiveness analysis, cost-utility analysis,
and cost-benefit analysis.
Cost-effectiveness analysis: societal perspective The
cost-effectiveness analysis (CEA) in this study will be
evaluated from the societal perspective (that is, all costs
related to the intervention will be taken into account ir-
respective of who pays for them). Costs consist of direct
medical costs (that is, intervention costs, health care
usage and travelling costs) and indirect costs (that is,
productivity loss in paid work due to absenteeism and
presenteeism). All costs will be summated for each indi-
vidual patient. All summated costs will be indexed in
euros for the reference year 2015. We will follow the
friction cost method with a friction cost period of 160
days and an elasticity of 0.8 for the calculation of absen-
teeism costs [56], as recommended by the Dutch guide-
line for health economic evaluations [35] and described
in detail elsewhere [34, 56]. To calculate the presentee-
ism costs, the costs of productivity losses will be multi-
plied by the number of workdays lost, with age and
gender-specific productivity levels per paid employee
indexed for the year 2015 [34, 35].
Both the incremental costs and incremental effects will
be used to calculate the incremental cost-effectiveness
ratio (ICER). The ICER will be calculated as (C1 − C0)/
(E1 − E0), where C denotes the average per-participant
costs and E denotes the effect on work participation in
the 40-h and 100-h VR groups (subscripted 1 and 0). As
absenteeism data will be used for the assessment of the
effect ratio of the ICER, it will be excluded from the cost
ratio part of the ICER. The ICER can be interpreted as
the net costs (or savings) per extra unit of effect. In our
study, the extra unit of effect equals a 1-day increase in
work participation. To estimate uncertainty in the cost
and effect data, nonparametric bootstraps will be used
to simulate 5,000 ICERs [57]. To show statistical uncer-
tainty on the results of cost-effectiveness, each simulated
ICER will be plotted on a cost-effectiveness plane [58].
Although cost-effectiveness planes give a good impres-
sion of the uncertainty surrounding the ICER, they do
not provide a summary measure of the joint uncertainty
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effectiveness acceptability curves (CEAC), which will
provide insight into the probability that 40-h VR is cost-
effective in comparison with 100-h VR [25].
Cost-utility analysis A cost-utility analysis (CUA) will
be conducted in which the incremental costs per QALY
will be estimated and which will be presented on a cost-
effectiveness plane and CEAC. Public policymakers may
be interested in CUA because they can compare the re-
sults between several conditions and interventions [25].
Cost-benefit analysis: employer’s perspective As em-
ployers reimburse the work participation coordination
module in both the 40-h VR and 100-h VR, analysis
from the employer’s perspective (that is, only the costs
relevant to the employer will be considered, including
intervention, absenteeism, and presenteeism costs) is
useful. It is recommended to conduct cost-benefit ana-
lysis (CBA), in which both costs and consequences are
measured in monetary units. In accordance with van
Dongen et al. [25], we will perform a return on invest-
ment (ROI) analyses, in which three ROI metrics are cal-
culated: (1) net benefits (NB), (2) benefit-cost ratio
(BCR), and (3) ROI.
NB = benefits − costs
BCR = benefits/costs
ROI = (benefits − costs)/costs [*100]
Costs will be defined as intervention costs. Benefits
will be defined as the difference in monetized outcome
measures (that is, absenteeism and presenteeism costs)
between 100-h and 40-h VR during the measurement
period (that is, intervention period and follow-up, see
Fig. 2), with positive benefits indicating reduced spend-
ing in the 40-h group. To estimate uncertainty, 95 % CIs
around the benefit estimates and NB will be estimated
by means of bootstrap confidence intervals. Financial
returns of 40-h VR are positive if the following criteria
are met: NB > 0, BCR > 1, and ROI > 0 % [25].
Sensitivity analyses
To assess the robustness of the results on cost-
effectiveness, we will perform four sensitivity analyses.
First, analyses will be performed using the complete
cases only. Second, analyses will be performed in which
the lost productivity costs will be calculated according to
the human capital approach. In the human capital ap-
proach, total sick leave days are not fixed as in the fric-
tion cost approach, and elasticity is not required [25].
Third, analyses will be performed with sick leave and
healthcare usage data that are related to subacute or
chronic musculoskeletal pain. Fourth, the observed out-
liers with very high lost productivity will be excluded
from the analysis.Sample size
A sample size of 174 is calculated to be sufficient (with a
one-sided 95 % CI, 80 % power, alpha of 0.025, standard
deviation of 80 and a margin of non-inferiority of 30
days) to establish non-inferiority of 40-h VR. The sample
size calculation allowed for 15 % loss to follow-up - 10 %
expected from comparable studies [18, 59, 60] and 5 % ex-
pected due to the extension of the program in the 40-h
VR group. An intraclass correlation coefficient (ICC) of
0.05 is accounted for by the use of four rehabilitation cen-
ters with two clusters (40-h and 100-h VR) at each center
[61, 62]. Because of the difference in program hours be-
tween 40-h and 100-h VR, we expect 40-h VR to benefit
by 8 extra working days available during the inter-
vention period. We accounted for this in the power cal-
culation by using minus 8 as the expected mean
difference between 40-h and 100-h VR. In our power
calculation, we assumed a normal distribution of the
primary outcome work participation. If the data on the
primary outcome does not follow a normal distribution,
we will perform log transformations. As previously stated,
we will allow 28 % as the margin of non-inferiority when
the data is log transformed.
According to the number of patients expected to be
referred to the four participating rehabilitation centers
per year (approximately 350), and after accounting for
two-thirds of non-participation in the study according to
Lasagna Law [63], we expect an inclusion of 115 partici-
pants per year for this study. Hence, our inclusion
period will cover approximately 18 months, and the data
collection period will cover 2 years and 9 months.
Randomization
An independent statistician prepared the randomization
by using computer-generated randomization tables. To
prevent unequal randomization, employees are pre-
stratified by duration of sick leave (short-term <6 weeks
or long-term ≥6 weeks) and whether they are on full-
time (100 %) or part-time (≤99 %) sick leave. Block
randomization with blocks of four will be applied to en-
sure equal group sizes within each stratum. A separate
block randomization table is generated for each of the
four participating vocational rehabilitation centers. For
each stratum, the researcher will prepare opaque, se-
quentially numbered, and sealed coded envelopes, with a
note for either the 40-h VR or 100-h VR. After the
multidisciplinary screening (at baseline), the multidiscip-
linary screening team and rehabilitation physician will
fulfil all study criteria. If participants meet all criteria,
they will be allocated to 40-h or 100-h VR. Treatment al-
location will be performed by a member of the multidis-
ciplinary screening team (MST) at each center and can
be performed at the center or via telephone (this will
differ among the centers). The MST member hands over
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tient is asked to pick one of the envelopes, open the en-
velope and sign the note. In the case of telephone
allocation, the MST member will ask the patient to sign
informed consent and to return it via a reply envelope.
When the signed informed consent is received, the
MST member will perform the treatment allocation
without the patient. After randomization, a research
assistant will make an appointment for the patient’s
first intervention date.
Blinding
Blinding in this study is not possible because of the na-
ture of the intervention. However, the data analyst will
remain blinded to the allocation. Participants will
complete self-reported web-based questionnaires outside
the study setting, so the multidisciplinary intervention
team has no influence on the outcome assessment. After
randomization, all participants are labelled with a re-
search code consisting of a unique consecutive number.
An independent researcher will maintain the coding
scheme. Data analysis will be performed using this re-
search code to guarantee that analyses of the data by the
researcher will be blinded.
Co-interventions and compliance
The patients’ self-reported healthcare usage data will be
used for the assessment of co-interventions. Compliance
will be assessed using information about attendance to
the program and compliance to the treatment protocol
and will be assessed after each intervention session in an
electronic log by a member of the multidisciplinary
intervention team (MIT). Furthermore, the MIT mem-
ber will determine at discharge if the program was com-
pleted as planned. This will be assessed on a binary
scale: “program completed as planned,” or “program de-
viated.” In the latter case, a closed question follows: pro-
gram deviated due to “early discontinuation due to
adverse events such as accident, surgery, or major pri-
vate event,” “early discontinuation due to goals being
achieved,” “extension of intervention program due to
non-achievement of goals,” or “other reasons.” In the
case of an early discontinuation or extension of the pro-
gram, the number of deviated weeks will be reported.
The information about compliance will be applied to
perform the per protocol analyses.
Discussion
The purpose of the presented study is to evaluate the
effectiveness and cost-effectiveness of 40-h vocational
rehabilitation versus 100-h vocational rehabilitation
on work participation for sick-listed workers due to
subacute or chronic nonspecific musculoskeletal pain.
We hypothesize that there is non-inferiority on workparticipation after a 12-month follow-up period (in-
cluding the intervention period and 12 months follow-
up) between both programs, and we expect cost-
effectiveness of 40-h VR in comparison with 100-h
VR.
Context of this study
In the Netherlands, both employer and employee are re-
sponsible for the work participation process of the sick-
listed employee during the first 2 years of sick leave. The
employer and employee can be supported by a certified
reintegration company and/or an occupational physician
(OP). In the first 2 years of sickness, the employer is re-
sponsible for the costs of wage replacement, which is
regulated by the Dutch Gatekeeper Improvement Act
[64]. As a result of this act, the employer has to reim-
burse the work participation coordination module (costs:
approximately €1,200) for both interventions performed
in this study. The other intervention modules are reim-
bursed by healthcare insurers.
Methodological considerations
The first methodological consideration of this study is
that we were not able to fulfil the recommended steps
for the composition of a margin of non-inferiority [30,
65]. This was because there is currently no historical
data, such as meta-analysis, comparing the 100-h vo-
cational rehabilitation with usual care. However, our
non-inferiority margin is based on results from five
randomized controlled trials evaluating multidiscipli-
nary vocational rehabilitation compared with control
interventions (that is, usual care, such as occupational
physician, physical therapist, occupational therapist,
etcetera) [15, 17–19, 24]. These studies found 43 days
as the mean difference ((41.9 + 53.7 + 42 + 60.5 +
17.5)/5) in days on sick leave after one year follow-up
in favor of multidisciplinary vocational rehabilitation.
Consequently, we have decided that 30 is an accept-
able margin of non-inferiority. One can argue that
this limit is too wide, and that claiming non-inferior-
ity could be achieved too simply, but for claiming
non-inferiority, the upper bound of the one-sided 95
% confidence interval of the treatment effect differ-
ence (40-h VR – 100-h VR) must be 30 or less. Fur-
thermore, when the margin of non-inferiority of 30 is
reached after 12 months follow-up, this is in fact 13
days (43–30) better than if a patient had been re-
ferred to usual care (occupational physician, physical
therapist, occupational therapist, etcetera). A mean
saving of 10 sick days per year is considered the
smallest effect that would be clinically worthwhile
[66]. We therefore consider 30 as a reasonable margin
of non-inferiority. The second methodological consid-
eration of this study is the slight differences between
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each center has its own logistic restrictions, such as a
restriction in intervention facilities (that is, equip-
ment, building); and centers have evolved their own
methods over the years. This may lead to interpre-
tation issues in analyzing the blended results of the
four centers. However, we solved this problem by
multilevel analyses and by performing both interven-
tions at each center, that is, by randomizing at the
participant level. Although performing both interven-
tions at the center level may introduce contamination,
we consider that the advantages of randomization at
the participant level outweigh the disadvantages of
contamination.Strengths and limitations of this study
The first strength of this study is the assessment of the
primary outcome work participation with self-reported
questionnaires with a recall period of one month. This
recall period will prevent recall bias. In addition, self-
reported data about work participation has been shown to
be a reliable alternative compared with electronic data-
bases [67]. The second strength of this study is the ana-
lysis of the cost-effectiveness from both the societal and
the employer’s perspective. It is important to provide em-
ployers with information on the return on investment of
both interventions, as this will help them to consider the
right treatment. A third strength of this study is that we
consider presenteeism in the cost-effectiveness evaluation.
Although most cost-effectiveness studies do not assess
presenteeism [17, 18, 31, 35, 68], it is meaningful to take
into account since the costs related to it are enormous, as
shown by Lötters et al. [69], who found that for workers
who returned to work after musculoskeletal disorders, the
median loss for an 8-h workday was 1.6 h, and this
remained at 12-month follow-up. A final strength of this
study is the participation of four rehabilitation centers, all
working with the bio-psychosocial model as a blueprint.
This will increase the generalizability of this study.
A limitation of this study is that it is not possible to
blind the patients and the multidisciplinary intervention
and screening team. This may result in non-compliance
to the treatment protocol, because patients may be
aware of which intervention parts they do not receive
(especially in the 40-h VR group), whereas other patients
in the same group will receive all intervention modules
(see Appendix 1). When this deviation occurs on a large
scale in the 40-h VR group, this will harm conclusions
about non-inferiority. Another limitation of this study is
that we do not correct for compensation costs, that is,
when colleagues take over the work of the less produc-
tive employee in their regular working hours. This may
overestimate presenteeism costs [70].Implications for practice
This study will provide essential knowledge about the
dose-effect relation of vocational rehabilitation on work
participation for workers on sick leave due to subacute
or chronic musculoskeletal pain. The insights obtained
from this study can be implemented in vocational re-
habilitation practice, where centers would be able to
judge which program (40-h or 100-h) fit their patient
groups best. Moreover, if our hypothesis about the ef-
fectiveness and cost-effectiveness of 40-h VR compared
with 100-h VR is valid, this will be beneficial for patients,
employers, and health care insurers. Patients will benefit
from a decline in intervention hours, which will result in
more time for work participation and leisure. Employers
will benefit from a higher return on their investments,
and health care insurers will benefit from higher vol-
umes of patients who can participate in vocational re-
habilitation within the same amount of time and money
or the same number of patients with lower costs.
Trial status
Participant enrollment started in November 2014. Re-
cruitment is expected to be completed by the end of
August 2016, and the trial will conclude by the end of
December 2017.
Additional information
To place the results from the described cost-
effectiveness study in perspective, the authors of this
paper will also conduct a qualitative paper in which in-
terviews with a random selection of the study population
of the proposed RCT will be performed. The aim of
these interviews will be to determine barriers and facili-
tators of the 40-h and 100-h VR on work participation.
The authors will also conduct focus group interviews
with the multidisciplinary intervention teams to explore
their experiences with both programs.
Appendix 1: Intervention modules
Work participation coordination
Work participation coordination is carried out by a work
participation coordinator [71] and encompasses a work-
place visit, case management, and two evaluation mo-
ments. The workplace visit includes an ergonomic
workplace analysis and a consultation with employer
and employee (patient), with the aim of developing a
work participation plan. Case management consists of
individual coaching sessions with the patient and un-
planned ad hoc conversations with the patient during
the program. The coaching style of the work participa-
tion coordinator is mainly based on solution-focused
coaching [72, 73] and on empowerment [74]. The two
evaluation moments include a report on progression in
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and discharge.
Dosage: 10 hours in both programs.
Graded activity
Graded activity is based on the protocol designed by
Lindstrom [75, 76] and adjusted to the Dutch situation
[8, 32, 77]. The graded activity program is carried out by
a physical therapist. The purpose of graded activity is to
restore occupational functioning and to facilitate work
participation. During the program, the patient has an ac-
tive role and the physical therapist acts as a coach and
supervisor, using a hands-off approach [77]. Graded ac-
tivity is a time-contingent approach with an increase in
load and complexity of movements. To attain physical
reconditioning, the graded activity protocol may be sup-
plemented with endurance exercises.
Dosage: 60 hours (2 × 2 hours per week) for patients
in the 100-h VR group. The amount of graded activity in
the 40-h VR group will differ per patient.
Cognitive behavioral therapy
Cognitive behavioral therapy (CBT) is carried out by a
psychologist and consists of individual sessions, group
education, and unplanned ad hoc conversations during
the program. The CBT sessions are based on solution-
focused coaching [72, 73] and empowerment [74]. It en-
compasses items such as coping, cognition, communica-
tion, and self-control.
Dosage: the dosage differs per patient, but we factor in
approximately 30 minutes per week for patients in the
100-h VR group, resulting in a total of 7.5 h. The amount
of CBT in the 40-h VR group will differ per patient.
Group education
Group education encompasses physical and mental
topics, and will be carried out by a physical therapist
and a psychologist. Physical topics are the effect of phys-
ical activity on the body (that is, training principles),
chronic and acute pain, pain sensitization, anatomy and
ergonomics, and pre- and post-exercise nutritional rec-
ommendations. Mental topics are empowerment, setting
graded tasks, cognitive behavioral therapy, and coping
with pain.
Dosage: 15 h (60 minutes per week) for patients in the
100-h VR group. The amount of group education in the
40-h VR group will differ per patient.
Relaxation
Relaxation sessions are carried out by a physical therap-
ist. Different techniques are employed, such as medita-
tion, visualization, autogenic training, mindfulness,
breath control, progressive relaxation, and reciprocal in-
hibition. The aim of relaxation is improved bodyawareness and experiencing the difference between ten-
sion and relaxation of the muscles.
Dosage: 7.5 h (30 minutes per week) for patients in
the 100-h VR group. The amount of relaxation in the
40-h VR group will differ per patient.
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